Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/23507| Title: | Testosterone therapy considerations in estrogen, progesterone and androgen receptor positive breast cancer in a transgender male. | Austin Authors: | Light, Melanie;McFarlane, Thomas;Ives, Andrew;Shah, Bhaumik;Lim, Elgene;Grossmann, Mathis ;Zajac, Jeffrey D ;Cheung, Ada S | Affiliation: | St Vincent's Clinical School, University of New South Wales, Darlinghurst, Sydney, Australia Endocrinology Aurora Specialists Care, Fitzroy, Australia Masada Private Hospital, St Kilda East, Australia Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia Medicine (University of Melbourne) |
Issue Date: | Sep-2020 | Date: | 2020-06-10 | Publication information: | Clinical Endocrinology 2020; 93(3): 355-357 | Abstract: | A 44-year-old premenopausal individual assigned female at birth but with a male gender identity, presented requesting masculinizing hormone therapy for long-standing gender dysphoria. His past medical history was unremarkable, and being adopted, his family history was unknown. Baseline blood tests and hormonal panel were within female reference ranges (Table). | URI: | https://ahro.austin.org.au/austinjspui/handle/1/23507 | DOI: | 10.1111/cen.14263 | ORCID: | 0000-0002-1213-6410 0000-0001-5257-5525 0000-0003-3933-5708 0000-0001-8261-3457 |
Journal: | Clinical Endocrinology | PubMed URL: | 32521051 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.